Medical Care
Global Immuno-Oncology Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Aug 11, 25
- ID: 437681
- Pages: 76
- Figures: 77
- Views: 3
The global Immuno-Oncology market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Bristol-Myers Squibb
Merck & Co., Inc.
Roche AG
AstraZeneca, Plc
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA
By Type: (Dominant Segment vs High-Margin Innovation)
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospitals
Drugstores
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Bristol-Myers Squibb in Europe)
- Emerging Product Trends: Immune Checkpoint Inhibitors adoption vs. Cytokine-Based Immunotherapy premiumization
- Demand-Side Dynamics: Hospitals growth in China vs. Drugstores potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
Southeast Asia
Central & South America
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Immuno-Oncology market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Cytokine-Based Immunotherapy in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Drugstores in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Immuno-Oncology value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Market Segmentation
By Company:
Bristol-Myers Squibb
Merck & Co., Inc.
Roche AG
AstraZeneca, Plc
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA
By Type: (Dominant Segment vs High-Margin Innovation)
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospitals
Drugstores
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Bristol-Myers Squibb in Europe)
- Emerging Product Trends: Immune Checkpoint Inhibitors adoption vs. Cytokine-Based Immunotherapy premiumization
- Demand-Side Dynamics: Hospitals growth in China vs. Drugstores potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
Southeast Asia
Central & South America
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Immuno-Oncology market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Cytokine-Based Immunotherapy in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Drugstores in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Immuno-Oncology value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Cytokine-Based Immunotherapy
1.2.4 Cancer Vaccines
1.2.5 CAR-T Cell Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immuno-Oncology Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Immuno-Oncology Revenue Market Share by Region (2020-2025)
2.4 Global Immuno-Oncology Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Immuno-Oncology Market Size and Prospective (2020-2031)
2.5.2 Europe Immuno-Oncology Market Size and Prospective (2020-2031)
2.5.3 China Immuno-Oncology Market Size and Prospective (2020-2031)
2.5.4 Japan Immuno-Oncology Market Size and Prospective (2020-2031)
2.5.5 India Immuno-Oncology Market Size and Prospective (2020-2031)
2.5.6 Southeast Asia Immuno-Oncology Market Size and Prospective (2020-2031)
2.5.7 Central & South America Immuno-Oncology Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Immuno-Oncology Historic Market Size by Type (2020-2025)
3.2 Global Immuno-Oncology Forecasted Market Size by Type (2026-2031)
3.3 Different Types Immuno-Oncology Representative Players
4 Breakdown Data by Application
4.1 Global Immuno-Oncology Historic Market Size by Application (2020-2025)
4.2 Global Immuno-Oncology Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Immuno-Oncology Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Immuno-Oncology Players by Revenue (2020-2025)
5.1.2 Global Immuno-Oncology Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Immuno-Oncology Revenue
5.4 Global Immuno-Oncology Market Concentration Analysis
5.4.1 Global Immuno-Oncology Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Revenue in 2024
5.5 Global Key Players of Immuno-Oncology Head office and Area Served
5.6 Global Key Players of Immuno-Oncology, Product and Application
5.7 Global Key Players of Immuno-Oncology, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Immuno-Oncology Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Immuno-Oncology Market Size by Type (2020-2025)
6.1.2.2 North America Immuno-Oncology Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Immuno-Oncology Market Size by Application (2020-2025)
6.1.3.2 North America Immuno-Oncology Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Immuno-Oncology Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Immuno-Oncology Market Size by Type (2020-2025)
6.2.2.2 Europe Immuno-Oncology Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Immuno-Oncology Market Size by Application (2020-2025)
6.2.3.2 Europe Immuno-Oncology Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Immuno-Oncology Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Immuno-Oncology Market Size by Type (2020-2025)
6.3.2.2 China Immuno-Oncology Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Immuno-Oncology Market Size by Application (2020-2025)
6.3.3.2 China Immuno-Oncology Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Immuno-Oncology Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Immuno-Oncology Market Size by Type (2020-2025)
6.4.2.2 Japan Immuno-Oncology Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Immuno-Oncology Market Size by Application (2020-2025)
6.4.3.2 Japan Immuno-Oncology Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments and Downstream
6.5.1 India Immuno-Oncology Revenue by Company (2020-2025)
6.5.2 India Market Size by Type
6.5.2.1 India Immuno-Oncology Market Size by Type (2020-2025)
6.5.2.2 India Immuno-Oncology Market Share by Type (2020-2025)
6.5.3 India Market Size by Application
6.5.3.1 India Immuno-Oncology Market Size by Application (2020-2025)
6.5.3.2 India Immuno-Oncology Market Share by Application (2020-2025)
6.5.4 India Market Trend and Opportunities
6.6 Southeast Asia Market: Players, Segments and Downstream
6.6.1 Southeast Asia Immuno-Oncology Revenue by Company (2020-2025)
6.6.2 Southeast Asia Market Size by Type
6.6.2.1 Southeast Asia Immuno-Oncology Market Size by Type (2020-2025)
6.6.2.2 Southeast Asia Immuno-Oncology Market Share by Type (2020-2025)
6.6.3 Southeast Asia Market Size by Application
6.6.3.1 Southeast Asia Immuno-Oncology Market Size by Application (2020-2025)
6.6.3.2 Southeast Asia Immuno-Oncology Market Share by Application (2020-2025)
6.6.4 Southeast Asia Market Trend and Opportunities
7 Key Players Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Company Details
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Immuno-Oncology Introduction
7.1.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2020-2025)
7.1.5 Bristol-Myers Squibb Recent Development
7.2 Merck & Co., Inc.
7.2.1 Merck & Co., Inc. Company Details
7.2.2 Merck & Co., Inc. Business Overview
7.2.3 Merck & Co., Inc. Immuno-Oncology Introduction
7.2.4 Merck & Co., Inc. Revenue in Immuno-Oncology Business (2020-2025)
7.2.5 Merck & Co., Inc. Recent Development
7.3 Roche AG
7.3.1 Roche AG Company Details
7.3.2 Roche AG Business Overview
7.3.3 Roche AG Immuno-Oncology Introduction
7.3.4 Roche AG Revenue in Immuno-Oncology Business (2020-2025)
7.3.5 Roche AG Recent Development
7.4 AstraZeneca, Plc
7.4.1 AstraZeneca, Plc Company Details
7.4.2 AstraZeneca, Plc Business Overview
7.4.3 AstraZeneca, Plc Immuno-Oncology Introduction
7.4.4 AstraZeneca, Plc Revenue in Immuno-Oncology Business (2020-2025)
7.4.5 AstraZeneca, Plc Recent Development
7.5 Sanofi S.A.
7.5.1 Sanofi S.A. Company Details
7.5.2 Sanofi S.A. Business Overview
7.5.3 Sanofi S.A. Immuno-Oncology Introduction
7.5.4 Sanofi S.A. Revenue in Immuno-Oncology Business (2020-2025)
7.5.5 Sanofi S.A. Recent Development
7.6 Dendreon Pharmaceuticals
7.6.1 Dendreon Pharmaceuticals Company Details
7.6.2 Dendreon Pharmaceuticals Business Overview
7.6.3 Dendreon Pharmaceuticals Immuno-Oncology Introduction
7.6.4 Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2020-2025)
7.6.5 Dendreon Pharmaceuticals Recent Development
7.7 Novartis
7.7.1 Novartis Company Details
7.7.2 Novartis Business Overview
7.7.3 Novartis Immuno-Oncology Introduction
7.7.4 Novartis Revenue in Immuno-Oncology Business (2020-2025)
7.7.5 Novartis Recent Development
7.8 Gilead Sciences Inc.
7.8.1 Gilead Sciences Inc. Company Details
7.8.2 Gilead Sciences Inc. Business Overview
7.8.3 Gilead Sciences Inc. Immuno-Oncology Introduction
7.8.4 Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2020-2025)
7.8.5 Gilead Sciences Inc. Recent Development
7.9 Merck KGaA
7.9.1 Merck KGaA Company Details
7.9.2 Merck KGaA Business Overview
7.9.3 Merck KGaA Immuno-Oncology Introduction
7.9.4 Merck KGaA Revenue in Immuno-Oncology Business (2020-2025)
7.9.5 Merck KGaA Recent Development
8 Immuno-Oncology Market Dynamics
8.1 Immuno-Oncology Industry Trends
8.2 Immuno-Oncology Market Drivers
8.3 Immuno-Oncology Market Challenges
8.4 Immuno-Oncology Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Cytokine-Based Immunotherapy
1.2.4 Cancer Vaccines
1.2.5 CAR-T Cell Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immuno-Oncology Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Immuno-Oncology Revenue Market Share by Region (2020-2025)
2.4 Global Immuno-Oncology Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Immuno-Oncology Market Size and Prospective (2020-2031)
2.5.2 Europe Immuno-Oncology Market Size and Prospective (2020-2031)
2.5.3 China Immuno-Oncology Market Size and Prospective (2020-2031)
2.5.4 Japan Immuno-Oncology Market Size and Prospective (2020-2031)
2.5.5 India Immuno-Oncology Market Size and Prospective (2020-2031)
2.5.6 Southeast Asia Immuno-Oncology Market Size and Prospective (2020-2031)
2.5.7 Central & South America Immuno-Oncology Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Immuno-Oncology Historic Market Size by Type (2020-2025)
3.2 Global Immuno-Oncology Forecasted Market Size by Type (2026-2031)
3.3 Different Types Immuno-Oncology Representative Players
4 Breakdown Data by Application
4.1 Global Immuno-Oncology Historic Market Size by Application (2020-2025)
4.2 Global Immuno-Oncology Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Immuno-Oncology Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Immuno-Oncology Players by Revenue (2020-2025)
5.1.2 Global Immuno-Oncology Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Immuno-Oncology Revenue
5.4 Global Immuno-Oncology Market Concentration Analysis
5.4.1 Global Immuno-Oncology Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Revenue in 2024
5.5 Global Key Players of Immuno-Oncology Head office and Area Served
5.6 Global Key Players of Immuno-Oncology, Product and Application
5.7 Global Key Players of Immuno-Oncology, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Immuno-Oncology Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Immuno-Oncology Market Size by Type (2020-2025)
6.1.2.2 North America Immuno-Oncology Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Immuno-Oncology Market Size by Application (2020-2025)
6.1.3.2 North America Immuno-Oncology Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Immuno-Oncology Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Immuno-Oncology Market Size by Type (2020-2025)
6.2.2.2 Europe Immuno-Oncology Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Immuno-Oncology Market Size by Application (2020-2025)
6.2.3.2 Europe Immuno-Oncology Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Immuno-Oncology Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Immuno-Oncology Market Size by Type (2020-2025)
6.3.2.2 China Immuno-Oncology Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Immuno-Oncology Market Size by Application (2020-2025)
6.3.3.2 China Immuno-Oncology Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Immuno-Oncology Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Immuno-Oncology Market Size by Type (2020-2025)
6.4.2.2 Japan Immuno-Oncology Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Immuno-Oncology Market Size by Application (2020-2025)
6.4.3.2 Japan Immuno-Oncology Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments and Downstream
6.5.1 India Immuno-Oncology Revenue by Company (2020-2025)
6.5.2 India Market Size by Type
6.5.2.1 India Immuno-Oncology Market Size by Type (2020-2025)
6.5.2.2 India Immuno-Oncology Market Share by Type (2020-2025)
6.5.3 India Market Size by Application
6.5.3.1 India Immuno-Oncology Market Size by Application (2020-2025)
6.5.3.2 India Immuno-Oncology Market Share by Application (2020-2025)
6.5.4 India Market Trend and Opportunities
6.6 Southeast Asia Market: Players, Segments and Downstream
6.6.1 Southeast Asia Immuno-Oncology Revenue by Company (2020-2025)
6.6.2 Southeast Asia Market Size by Type
6.6.2.1 Southeast Asia Immuno-Oncology Market Size by Type (2020-2025)
6.6.2.2 Southeast Asia Immuno-Oncology Market Share by Type (2020-2025)
6.6.3 Southeast Asia Market Size by Application
6.6.3.1 Southeast Asia Immuno-Oncology Market Size by Application (2020-2025)
6.6.3.2 Southeast Asia Immuno-Oncology Market Share by Application (2020-2025)
6.6.4 Southeast Asia Market Trend and Opportunities
7 Key Players Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Company Details
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Immuno-Oncology Introduction
7.1.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2020-2025)
7.1.5 Bristol-Myers Squibb Recent Development
7.2 Merck & Co., Inc.
7.2.1 Merck & Co., Inc. Company Details
7.2.2 Merck & Co., Inc. Business Overview
7.2.3 Merck & Co., Inc. Immuno-Oncology Introduction
7.2.4 Merck & Co., Inc. Revenue in Immuno-Oncology Business (2020-2025)
7.2.5 Merck & Co., Inc. Recent Development
7.3 Roche AG
7.3.1 Roche AG Company Details
7.3.2 Roche AG Business Overview
7.3.3 Roche AG Immuno-Oncology Introduction
7.3.4 Roche AG Revenue in Immuno-Oncology Business (2020-2025)
7.3.5 Roche AG Recent Development
7.4 AstraZeneca, Plc
7.4.1 AstraZeneca, Plc Company Details
7.4.2 AstraZeneca, Plc Business Overview
7.4.3 AstraZeneca, Plc Immuno-Oncology Introduction
7.4.4 AstraZeneca, Plc Revenue in Immuno-Oncology Business (2020-2025)
7.4.5 AstraZeneca, Plc Recent Development
7.5 Sanofi S.A.
7.5.1 Sanofi S.A. Company Details
7.5.2 Sanofi S.A. Business Overview
7.5.3 Sanofi S.A. Immuno-Oncology Introduction
7.5.4 Sanofi S.A. Revenue in Immuno-Oncology Business (2020-2025)
7.5.5 Sanofi S.A. Recent Development
7.6 Dendreon Pharmaceuticals
7.6.1 Dendreon Pharmaceuticals Company Details
7.6.2 Dendreon Pharmaceuticals Business Overview
7.6.3 Dendreon Pharmaceuticals Immuno-Oncology Introduction
7.6.4 Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2020-2025)
7.6.5 Dendreon Pharmaceuticals Recent Development
7.7 Novartis
7.7.1 Novartis Company Details
7.7.2 Novartis Business Overview
7.7.3 Novartis Immuno-Oncology Introduction
7.7.4 Novartis Revenue in Immuno-Oncology Business (2020-2025)
7.7.5 Novartis Recent Development
7.8 Gilead Sciences Inc.
7.8.1 Gilead Sciences Inc. Company Details
7.8.2 Gilead Sciences Inc. Business Overview
7.8.3 Gilead Sciences Inc. Immuno-Oncology Introduction
7.8.4 Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2020-2025)
7.8.5 Gilead Sciences Inc. Recent Development
7.9 Merck KGaA
7.9.1 Merck KGaA Company Details
7.9.2 Merck KGaA Business Overview
7.9.3 Merck KGaA Immuno-Oncology Introduction
7.9.4 Merck KGaA Revenue in Immuno-Oncology Business (2020-2025)
7.9.5 Merck KGaA Recent Development
8 Immuno-Oncology Market Dynamics
8.1 Immuno-Oncology Industry Trends
8.2 Immuno-Oncology Market Drivers
8.3 Immuno-Oncology Market Challenges
8.4 Immuno-Oncology Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Immuno-Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Immuno-Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Immuno-Oncology Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Immuno-Oncology Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Immuno-Oncology Revenue Share by Region (2020-2025)
Table 6. Global Immuno-Oncology Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Immuno-Oncology Revenue Share Forecast by Region (2026-2031)
Table 8. Global Immuno-Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Immuno-Oncology Revenue Market Share by Type (2020-2025)
Table 10. Global Immuno-Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Immuno-Oncology Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Immuno-Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Immuno-Oncology Revenue Market Share by Application (2020-2025)
Table 15. Global Immuno-Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Immuno-Oncology Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Immuno-Oncology Application
Table 18. Global Immuno-Oncology Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Immuno-Oncology Market Share by Players (2020-2025)
Table 20. Global Top Immuno-Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology as of 2024)
Table 21. Ranking of Global Top Immuno-Oncology Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Immuno-Oncology Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Immuno-Oncology, Headquarters and Area Served
Table 24. Global Key Players of Immuno-Oncology, Product and Application
Table 25. Global Key Players of Immuno-Oncology, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Immuno-Oncology Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Immuno-Oncology Revenue Market Share by Company (2020-2025)
Table 29. North America Immuno-Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Immuno-Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Immuno-Oncology Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Immuno-Oncology Revenue Market Share by Company (2020-2025)
Table 33. Europe Immuno-Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Immuno-Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Immuno-Oncology Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Immuno-Oncology Revenue Market Share by Company (2020-2025)
Table 37. China Immuno-Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Immuno-Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Immuno-Oncology Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Immuno-Oncology Revenue Market Share by Company (2020-2025)
Table 41. Japan Immuno-Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Immuno-Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 43. India Immuno-Oncology Revenue by Company (2020-2025) & (US$ Million)
Table 44. India Immuno-Oncology Revenue Market Share by Company (2020-2025)
Table 45. India Immuno-Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 46. India Immuno-Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 47. Southeast Asia Immuno-Oncology Revenue by Company (2020-2025) & (US$ Million)
Table 48. Southeast Asia Immuno-Oncology Revenue Market Share by Company (2020-2025)
Table 49. Southeast Asia Immuno-Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 50. Southeast Asia Immuno-Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 51. Bristol-Myers Squibb Company Details
Table 52. Bristol-Myers Squibb Business Overview
Table 53. Bristol-Myers Squibb Immuno-Oncology Product
Table 54. Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 55. Bristol-Myers Squibb Recent Development
Table 56. Merck & Co., Inc. Company Details
Table 57. Merck & Co., Inc. Business Overview
Table 58. Merck & Co., Inc. Immuno-Oncology Product
Table 59. Merck & Co., Inc. Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 60. Merck & Co., Inc. Recent Development
Table 61. Roche AG Company Details
Table 62. Roche AG Business Overview
Table 63. Roche AG Immuno-Oncology Product
Table 64. Roche AG Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 65. Roche AG Recent Development
Table 66. AstraZeneca, Plc Company Details
Table 67. AstraZeneca, Plc Business Overview
Table 68. AstraZeneca, Plc Immuno-Oncology Product
Table 69. AstraZeneca, Plc Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 70. AstraZeneca, Plc Recent Development
Table 71. Sanofi S.A. Company Details
Table 72. Sanofi S.A. Business Overview
Table 73. Sanofi S.A. Immuno-Oncology Product
Table 74. Sanofi S.A. Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 75. Sanofi S.A. Recent Development
Table 76. Dendreon Pharmaceuticals Company Details
Table 77. Dendreon Pharmaceuticals Business Overview
Table 78. Dendreon Pharmaceuticals Immuno-Oncology Product
Table 79. Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 80. Dendreon Pharmaceuticals Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Immuno-Oncology Product
Table 84. Novartis Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Gilead Sciences Inc. Company Details
Table 87. Gilead Sciences Inc. Business Overview
Table 88. Gilead Sciences Inc. Immuno-Oncology Product
Table 89. Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 90. Gilead Sciences Inc. Recent Development
Table 91. Merck KGaA Company Details
Table 92. Merck KGaA Business Overview
Table 93. Merck KGaA Immuno-Oncology Product
Table 94. Merck KGaA Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 95. Merck KGaA Recent Development
Table 96. Immuno-Oncology Market Trends
Table 97. Immuno-Oncology Market Drivers
Table 98. Immuno-Oncology Market Challenges
Table 99. Immuno-Oncology Market Restraints
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Immuno-Oncology Product Picture
Figure 2. Global Immuno-Oncology Market Share by Type: 2024 VS 2031
Figure 3. Immune Checkpoint Inhibitors Features
Figure 4. Cytokine-Based Immunotherapy Features
Figure 5. Cancer Vaccines Features
Figure 6. CAR-T Cell Therapy Features
Figure 7. Others Features
Figure 8. Global Immuno-Oncology Market Share by Application: 2024 VS 2031
Figure 9. Hospitals
Figure 10. Drugstores
Figure 11. Others
Figure 12. Immuno-Oncology Report Years Considered
Figure 13. Global Immuno-Oncology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Immuno-Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Immuno-Oncology Revenue Market Share by Region: 2020 VS 2024
Figure 16. North America Immuno-Oncology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Europe Immuno-Oncology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. China Immuno-Oncology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Japan Immuno-Oncology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. India Immuno-Oncology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Southeast Asia Immuno-Oncology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Central & South America Immuno-Oncology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Global Immuno-Oncology Market Share by Players in 2024
Figure 24. Global Top Immuno-Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology as of 2024)
Figure 25. The Top 10 and 5 Players Market Share by Immuno-Oncology Revenue in 2024
Figure 26. North America Immuno-Oncology Market Share by Type (2020-2025)
Figure 27. North America Immuno-Oncology Market Share by Application (2020-2025)
Figure 28. Europe Immuno-Oncology Market Share by Type (2020-2025)
Figure 29. Europe Immuno-Oncology Market Share by Application (2020-2025)
Figure 30. China Immuno-Oncology Market Share by Type (2020-2025)
Figure 31. China Immuno-Oncology Market Share by Application (2020-2025)
Figure 32. Japan Immuno-Oncology Market Share by Type (2020-2025)
Figure 33. Japan Immuno-Oncology Market Share by Application (2020-2025)
Figure 34. India Immuno-Oncology Market Share by Type (2020-2025)
Figure 35. India Immuno-Oncology Market Share by Application (2020-2025)
Figure 36. Southeast Asia Immuno-Oncology Market Share by Type (2020-2025)
Figure 37. Southeast Asia Immuno-Oncology Market Share by Application (2020-2025)
Figure 38. Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 39. Merck & Co., Inc. Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 40. Roche AG Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 41. AstraZeneca, Plc Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 42. Sanofi S.A. Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 43. Dendreon Pharmaceuticals Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 44. Novartis Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 45. Gilead Sciences Inc. Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 46. Merck KGaA Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Table 1. Global Immuno-Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Immuno-Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Immuno-Oncology Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Immuno-Oncology Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Immuno-Oncology Revenue Share by Region (2020-2025)
Table 6. Global Immuno-Oncology Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Immuno-Oncology Revenue Share Forecast by Region (2026-2031)
Table 8. Global Immuno-Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Immuno-Oncology Revenue Market Share by Type (2020-2025)
Table 10. Global Immuno-Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Immuno-Oncology Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Immuno-Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Immuno-Oncology Revenue Market Share by Application (2020-2025)
Table 15. Global Immuno-Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Immuno-Oncology Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Immuno-Oncology Application
Table 18. Global Immuno-Oncology Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Immuno-Oncology Market Share by Players (2020-2025)
Table 20. Global Top Immuno-Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology as of 2024)
Table 21. Ranking of Global Top Immuno-Oncology Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Immuno-Oncology Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Immuno-Oncology, Headquarters and Area Served
Table 24. Global Key Players of Immuno-Oncology, Product and Application
Table 25. Global Key Players of Immuno-Oncology, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Immuno-Oncology Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Immuno-Oncology Revenue Market Share by Company (2020-2025)
Table 29. North America Immuno-Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Immuno-Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Immuno-Oncology Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Immuno-Oncology Revenue Market Share by Company (2020-2025)
Table 33. Europe Immuno-Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Immuno-Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Immuno-Oncology Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Immuno-Oncology Revenue Market Share by Company (2020-2025)
Table 37. China Immuno-Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Immuno-Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Immuno-Oncology Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Immuno-Oncology Revenue Market Share by Company (2020-2025)
Table 41. Japan Immuno-Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Immuno-Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 43. India Immuno-Oncology Revenue by Company (2020-2025) & (US$ Million)
Table 44. India Immuno-Oncology Revenue Market Share by Company (2020-2025)
Table 45. India Immuno-Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 46. India Immuno-Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 47. Southeast Asia Immuno-Oncology Revenue by Company (2020-2025) & (US$ Million)
Table 48. Southeast Asia Immuno-Oncology Revenue Market Share by Company (2020-2025)
Table 49. Southeast Asia Immuno-Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 50. Southeast Asia Immuno-Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 51. Bristol-Myers Squibb Company Details
Table 52. Bristol-Myers Squibb Business Overview
Table 53. Bristol-Myers Squibb Immuno-Oncology Product
Table 54. Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 55. Bristol-Myers Squibb Recent Development
Table 56. Merck & Co., Inc. Company Details
Table 57. Merck & Co., Inc. Business Overview
Table 58. Merck & Co., Inc. Immuno-Oncology Product
Table 59. Merck & Co., Inc. Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 60. Merck & Co., Inc. Recent Development
Table 61. Roche AG Company Details
Table 62. Roche AG Business Overview
Table 63. Roche AG Immuno-Oncology Product
Table 64. Roche AG Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 65. Roche AG Recent Development
Table 66. AstraZeneca, Plc Company Details
Table 67. AstraZeneca, Plc Business Overview
Table 68. AstraZeneca, Plc Immuno-Oncology Product
Table 69. AstraZeneca, Plc Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 70. AstraZeneca, Plc Recent Development
Table 71. Sanofi S.A. Company Details
Table 72. Sanofi S.A. Business Overview
Table 73. Sanofi S.A. Immuno-Oncology Product
Table 74. Sanofi S.A. Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 75. Sanofi S.A. Recent Development
Table 76. Dendreon Pharmaceuticals Company Details
Table 77. Dendreon Pharmaceuticals Business Overview
Table 78. Dendreon Pharmaceuticals Immuno-Oncology Product
Table 79. Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 80. Dendreon Pharmaceuticals Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Immuno-Oncology Product
Table 84. Novartis Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Gilead Sciences Inc. Company Details
Table 87. Gilead Sciences Inc. Business Overview
Table 88. Gilead Sciences Inc. Immuno-Oncology Product
Table 89. Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 90. Gilead Sciences Inc. Recent Development
Table 91. Merck KGaA Company Details
Table 92. Merck KGaA Business Overview
Table 93. Merck KGaA Immuno-Oncology Product
Table 94. Merck KGaA Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 95. Merck KGaA Recent Development
Table 96. Immuno-Oncology Market Trends
Table 97. Immuno-Oncology Market Drivers
Table 98. Immuno-Oncology Market Challenges
Table 99. Immuno-Oncology Market Restraints
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Immuno-Oncology Product Picture
Figure 2. Global Immuno-Oncology Market Share by Type: 2024 VS 2031
Figure 3. Immune Checkpoint Inhibitors Features
Figure 4. Cytokine-Based Immunotherapy Features
Figure 5. Cancer Vaccines Features
Figure 6. CAR-T Cell Therapy Features
Figure 7. Others Features
Figure 8. Global Immuno-Oncology Market Share by Application: 2024 VS 2031
Figure 9. Hospitals
Figure 10. Drugstores
Figure 11. Others
Figure 12. Immuno-Oncology Report Years Considered
Figure 13. Global Immuno-Oncology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Immuno-Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Immuno-Oncology Revenue Market Share by Region: 2020 VS 2024
Figure 16. North America Immuno-Oncology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Europe Immuno-Oncology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. China Immuno-Oncology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Japan Immuno-Oncology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. India Immuno-Oncology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Southeast Asia Immuno-Oncology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Central & South America Immuno-Oncology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Global Immuno-Oncology Market Share by Players in 2024
Figure 24. Global Top Immuno-Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology as of 2024)
Figure 25. The Top 10 and 5 Players Market Share by Immuno-Oncology Revenue in 2024
Figure 26. North America Immuno-Oncology Market Share by Type (2020-2025)
Figure 27. North America Immuno-Oncology Market Share by Application (2020-2025)
Figure 28. Europe Immuno-Oncology Market Share by Type (2020-2025)
Figure 29. Europe Immuno-Oncology Market Share by Application (2020-2025)
Figure 30. China Immuno-Oncology Market Share by Type (2020-2025)
Figure 31. China Immuno-Oncology Market Share by Application (2020-2025)
Figure 32. Japan Immuno-Oncology Market Share by Type (2020-2025)
Figure 33. Japan Immuno-Oncology Market Share by Application (2020-2025)
Figure 34. India Immuno-Oncology Market Share by Type (2020-2025)
Figure 35. India Immuno-Oncology Market Share by Application (2020-2025)
Figure 36. Southeast Asia Immuno-Oncology Market Share by Type (2020-2025)
Figure 37. Southeast Asia Immuno-Oncology Market Share by Application (2020-2025)
Figure 38. Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 39. Merck & Co., Inc. Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 40. Roche AG Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 41. AstraZeneca, Plc Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 42. Sanofi S.A. Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 43. Dendreon Pharmaceuticals Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 44. Novartis Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 45. Gilead Sciences Inc. Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 46. Merck KGaA Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232